On The Fly
| ShowHide Related Items >><< - 08:16 Today
- Allscripts in pact with Microsoft with MATTER and ARC Innovation Center
- 01/26/21
- Microsoft CEO says Office 365 to see increased usage depth
- 01/26/21
- Microsoft CEO says will see structurally changed tech environment post-Covid
- 01/26/21
- Microsoft sees Q3 Productivity and Business Processes revenue $13.35B-$13.6B
- $3,234.83 /
-93.15 (-2.80%) - 01/26/21
- User reports indicate AWS experiencing issues, says DownDetector
- 01/26/21
- Arrow Electronics expands relationship with Amazon Web Services
- 01/26/21
- Amazon to expand Boston Tech Hub, create over 3,000 jobs
- 01/19/21
- Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs
- 11:15 Today
- Boeing still expects to be cash flow positive in 2022
- 11:12 Today
- Boeing sees 2021 revenue improving from 2020
- 11:12 Today
- Boeing: 2021 to continue to be challenging, but sees upward trends from 2020
- 11:11 Today
- Boeing operating cash 'much improved' in 2021 vs. 2020
- 09:46 Today
- Starbucks CEO says 'no question in my mind' that 'third place' thesis is intact
- 09:44 Today
- Starbucks CEO says eliminated COO layer with Brewer's exit
- 09:41 Today
- Starbucks CEO says new store opening in China has accelerated
- 09:39 Today
- Starbucks CEO says 'not linear,' but tracking to recovery as expected
WBA Walgreens Boots Alliance - 01/26/21
- Walgreens Boots Alliances confirms appointment of Rosalind Brewer as CEO
- 01/26/21
- Walgreens Boots Alliance jumps 4% to $51.19 on report of new CEO appointment
- 01/22/21
- Walgreens Boots Alliance completes over 1M COVID-19 vaccines
- 01/21/21
- Adamis announces SYMJEPI, epinephrine injection products at Walgreens
- 08:55 Today
- AT&T sees increase in fiber build in FY21
- 08:49 Today
- AT&T sees FY21 wireless service revenue growth of ~2%
- 08:41 Today
- AT&T says retired more than 30 products in portfolio in 2020
- 06:40 Today
- AT&T: Total domestic HBO Max and HBO subscribers top 41M in Q4
- 08:42 Today
- Perspecta trading resumes
- 08:30 Today
- Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B
- 08:28 Today
- Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B
- 08:23 Today
- Perspecta trading halted, news pending
- $345.00 /
+199 (+136.30%) - 14:40 Today
- Powell, asked about GameStop, says 'I don't want to comment'
- 13:33 Today
- Biden economic team 'monitoring' GameStop trading activity
- 12:14 Today
- Palihapitiya says GameStop call profit of $500,000 to be donated
- 12:11 Today
- Chamath Palihapitiya closed out GameStop call position this morning
- $19.86 /
+14.92 (+302.02%) - 12:15 Today
- AMC Entertainment announces completion of at-the-market equity program
- 12:00 Today
- AMC Entertainment rises 212.1%
- 10:00 Today
- AMC Entertainment rises 247.6%
- 09:47 Today
- AMC Entertainment rises 242.9%
- 11:04 Today
- Vir Biotechnology trading resumes
- 10:59 Today
- Vir Biotechnology trading halted, volatility trading pause
- 06:49 Today
- Eli Lilly, Vir and GlaxoSmithKline announce collaboration
- 06:48 Today
- Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail
- 07:30 Today
- AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid
- 06:49 Today
- Eli Lilly, Vir and GlaxoSmithKline announce collaboration
- 06:48 Today
- Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail
- 01/26/21
- Eli Lilly: Etesevimab, bamlanivimab reduced risk of Covid hospitalizations
- 08:32 Today
- Sanofi's priority is to continue to develop two Covid vaccine candidates
- 07:30 Today
- AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid
- 06:49 Today
- Eli Lilly, Vir and GlaxoSmithKline announce collaboration
- 06:48 Today
- Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail
- $290.18 /
-22.33 (-7.15%) - 06:07 Today
- Anthem sees FY21 operating cash flow greater than $5.7B
- 06:06 Today
- Anthem sees FY21 medical membership 44.1M-44.7M
- 06:05 Today
- Anthem raises quarterly divdend to $1.13 from 95c per share
- 06:04 Today
- Anthem announces $5B increase to share repurchase program
- 09:14 Today JPMorgan
- Microsoft price target raised to $245 from $220 at JPMorgan
- 08:47 Today Wedbush
- Microsoft price target raised to $285 from $270 at Wedbush
- 08:27 Today UBS
- Microsoft price target raised to $267 from $243 at UBS
- 08:23 Today Credit Suisse
- Microsoft price target raised to $265 from $235 at Credit Suisse
- $3,234.83 /
-93.15 (-2.80%) - 08:57 Today JPMorgan
- Amazon.com price target raised to $4,155 from $4,100 at JPMorgan
- 07:41 Today Stifel
- Amazon.com price target raised to $3,600 from $3,500 at Stifel
- 01/25/21 Morgan Stanley
- Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
- 01/25/21 Loop Capital
- Bed Bath & Beyond price target raised to $30 from $18 at Loop Capital
- 01/20/21
- Fly Intel: Top five analyst upgrades
- 01/20/21 Berenberg
- Boeing upgraded to Hold from Sell at Berenberg
- 01/04/21
- Fly Intel: Top five analyst downgrades
- 01/04/21 Baird
- Boeing elevated to Fresh Pick at Baird
- 07:16 Today Barclays
- Starbucks price target raised to $125 from $122 at Barclays
- 07:11 Today Morgan Stanley
- Starbucks price target raised to $110 from $106 at Morgan Stanley
- 06:34 Today Citi
- Starbucks price target raised to $119 from $111 at Citi
- 06:22 Today Piper Sandler
- Starbucks price target raised to $104 from $100 at Piper Sandler
WBA Walgreens Boots Alliance - 06:50 Today Deutsche Bank
- Walgreens Boots Alliance price target raised to $49 from $44 at Deutsche Bank
- 01/15/21 Baird
- Walgreens Boots Alliance price target raised to $64 from $55 at Baird
- 01/11/21
- Fly Intel: Top five analyst upgrades
- 01/11/21 Baird
- Baird upgrades Walgreens Boots Alliance following Q1 results
- 12:12 Today MoffettNathanson
- AT&T leverage 'too high for a shrinking company,' says MoffettNathanson
- 01/04/21
- Fly Intel: Top five analyst upgrades
- 01/04/21 Raymond James
- AT&T upgraded to Outperform from Market Perform at Raymond James
- 01/04/21 Raymond James
- AT&T upgraded to Outperform from Market Perform at Raymond James
- 09:59 Today Stifel
- CACI 'very likely' to bid on Perspecta as well, says Stifel
- 06/12/20 William Blair
- William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
- 04/02/20 Wells Fargo
- Perspecta price target lowered to $18.50 from $26 at Wells Fargo
- 03/30/20 William Blair
- Perspecta initiated with a Market Perform at William Blair
- $345.00 /
+199 (+136.30%) - 08:23 Today BofA
- With GameStop shares trading at $213.50, BofA raises price target to $10
- 01/25/21 KeyBanc
- Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc
- 01/25/21
- Fly Intel: Top five analyst downgrades
- 01/25/21 Telsey Advisory
- GameStop continues surge despite double downgrade at Telsey Advisory
- $19.86 /
+14.92 (+302.02%) - 01/26/21 Loop Capital
- AMC Entertainment's capital raise results in massive dilution, says Loop Capital
- 01/26/21 B. Riley Securities
- AMC Entertainment price target raised to $5.50 from $3.50 at B. Riley Securities
- 12/28/20 B. Riley Securities
- 'Wonder Women' opens well above expectations, says B. Riley Securities
- 12/04/20 B. Riley Securities
- Theater selloff on Warner Bros. news likely an overreaction, says B. Riley
- 13:04 Today JPMorgan
- Vir Biotechnology added to analyst focus list as short idea at JPMorgan
- 11:13 Today H.C. Wainwright
- Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program
- 07:00 Today JPMorgan
- Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan
- 04:52 Today JPMorgan
- Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan
- 11:13 Today H.C. Wainwright
- Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program
- 01/26/21 Berenberg
- Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
- 01/20/21 Citi
- Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
- 01/19/21 Roth Capital
- Merus price target raised to $32 from $19 at Roth Capital
- 11:13 Today H.C. Wainwright
- Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program
- 01/26/21 Piper Sandler
- Amarin in 'strong position' against Health Net, says Piper Sandler
- 01/20/21 UBS
- GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS
- 01/20/21
- Fly Intel: Top five analyst downgrades
- $290.18 /
-22.33 (-7.15%) - 01/26/21 Cowen
- Anthem price target raised to $360 from $330 at Cowen
- 01/15/21 Jefferies
- Anthem upgraded to Buy on more constructive commercial outlook at Jefferies
- 01/15/21 Jefferies
- Anthem upgraded to Buy from Hold at Jefferies
- 01/13/21 Argus
- Anthem price target raised to $380 from $300 at Argus
- 01/26/21
- Microsoft reports Q2 EPS $2.03, consensus $1.64
- 01/26/21
- Notable companies reporting after market close
- 10/27/20
- Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B
- 10/27/20
- Microsoft reports Q1 EPS $1.82, consensus $1.54
- $3,234.83 /
-93.15 (-2.80%) - 01/14/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 10/29/20
- Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B
- 10/29/20
- Amazon.com reports Q3 EPS $12.37, consensus $7.41
- 07/30/20
- Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B
- 07:30 Today
- Boeing reports Q4 core EPS ($15.25), consensus ($1.80)
- 01/26/21
- Notable companies reporting before tomorrow's open
- 01/26/21
- Notable companies reporting before tomorrow's open
- 10/28/20
- Boeing reports Q3 core EPS ($1.39), consensus ($2.32)
- 01/26/21
- Starbucks sees January U.S. SSS down 2%
- 01/26/21
- Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B
- 01/26/21
- Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81
- 01/26/21
- Starbucks sees Q2 EPS 45c-50c, consensus 59c
WBA Walgreens Boots Alliance - 01/07/21
- Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits
- 01/07/21
- Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03
- 01/06/21
- Notable companies reporting before tomorrow's open
- 01/06/21
- Notable companies reporting before tomorrow's open
- 06:35 Today
- AT&T expects FY21 adjusted EPS to be stable with 2020, consensus $3.16
- 06:34 Today
- AT&T reports Q4 adjusted EPS 75c, consensus 73c
- 01/26/21
- Notable companies reporting before tomorrow's open
- 01/26/21
- Notable companies reporting before tomorrow's open
- 11/10/20
- Perspecta raises FY21 adj. EPS view to $2.03-$2.11 from $1.90-$2.03
- 11/10/20
- Perspecta reports Q2 adjusted EPS 53c, consensus 50c
- 08/06/20
- Perspecta backs FY21 adjusted EPS view $1.90-$2.03, consensus $1.95
- 08/06/20
- Perspecta reports Q1 adjusted EPS 47c, consensus 45c
- $345.00 /
+199 (+136.30%) - 12/08/20
- GameStop reports Q3 adj. EPS (53c), consensus (85c)
- 12/08/20
- GameStop reports Q3 EPS (29c), consensus (85c)
- 12/08/20
- Notable companies reporting after market close
- 09/09/20
- GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13)
- $19.86 /
+14.92 (+302.02%) - 11/02/20
- AMC Entertainment reports Q3 adjusted EPS ($5.70), consensus ($4.95)
- 11/02/20
- Notable companies reporting after market close
- 10/20/20
- AMC Entertainment sees Q3 revenue roughly $119.5M, consensus $155.31M
- 08/06/20
- AMC Entertainment reports Q2 adjusted EPS ($5.44), consensus ($4.29)
- 11/10/20
- Vir Biotechnology reports Q3 EPS (67c), consensus (60c)
- 08/11/20
- Vir Biotechnology reports Q2 EPS (27c), consensus (62c)
- 12/15/20
- Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07
- 12/15/20
- Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32
- 12/02/20
- Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c
- 10/27/20
- Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28
- 10/28/20
- GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range
- 10/28/20
- GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago
- 10/08/20
- GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5%
- 07/29/20
- GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER
- $290.18 /
-22.33 (-7.15%) - 06:02 Today
- Anthem sees FY21 adjusted EPS greater than $24.50, consensus $25.34
- 06:00 Today
- Anthem reports Q4 adjusted EPS $2.54, consensus $2.52
- 01/26/21
- Notable companies reporting before tomorrow's open
- 01/26/21
- Notable companies reporting before tomorrow's open
|